Research programme: HIV vaccine - Pecan BiotherapeuticsAlternative Names: Tat Oyi vaccine - Pecan Biotherapeutics; Tat Oyi-Cys22 vaccine - Pecan Biotherapeutics; Therapeutic HIV vaccine - Pecan Biotherapeutics; Third-generation HIV vaccine (Tat Oyi-Cys22) - Pecan Biotherapeutics
Latest Information Update: 25 Feb 2010
At a glance
- Originator Pecan Biotherapeutics
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical HIV infections
Most Recent Events
- 25 Feb 2010 Preclinical development is ongoing in USA